pd 98059 has been researched along with Acute Liver Injury, Drug-Induced in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marra, F | 1 |
Arrighi, MC | 1 |
Fazi, M | 1 |
Caligiuri, A | 1 |
Pinzani, M | 1 |
Romanelli, RG | 1 |
Efsen, E | 1 |
Laffi, G | 1 |
Gentilini, P | 1 |
1 other study available for pd 98059 and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Carbon Tetrachloride; Cell Division; Cell Mov | 1999 |